BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37550153)

  • 1. Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review.
    Motzer RJ; Rane PP; Saretsky TL; Pawar D; Martin Nguyen A; Sundaram M; Burgents J; Pandey R; Rudell K
    Eur Urol; 2023 Oct; 84(4):406-417. PubMed ID: 37550153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of patient-reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic review.
    Malone E; Barua R; Meti N; Li X; Fazelzad R; Hansen AR
    Cancer Med; 2021 Aug; 10(15):5031-5040. PubMed ID: 34184416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
    Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
    Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of outcomes and endpoints in acute migraine clinical trials.
    Houts CR; McGinley JS; Nishida TK; Buse DC; Wirth RJ; Dodick DW; Goadsby PJ; Lipton RB
    Headache; 2021 Feb; 61(2):263-275. PubMed ID: 33611818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAU guidelines on renal cell carcinoma: 2014 update.
    Ljungberg B; Bensalah K; Canfield S; Dabestani S; Hofmann F; Hora M; Kuczyk MA; Lam T; Marconi L; Merseburger AS; Mulders P; Powles T; Staehler M; Volpe A; Bex A
    Eur Urol; 2015 May; 67(5):913-24. PubMed ID: 25616710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples.
    Brogan AP; DeMuro C; Barrett AM; D'Alessio D; Bal V; Hogue SL
    J Manag Care Spec Pharm; 2017 Feb; 23(2):125-134. PubMed ID: 28125369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer.
    Beyer K; Widdershoven C; Wintner LM; Dabestani S; Marconi L; Moss C; Kinsella N; Yuan Y; Giles RH; Barod R; Van Hemelrijck M; Bex A; Zondervan P; MacLennan S
    Eur Urol Open Sci; 2023 Feb; 48():1-11. PubMed ID: 36578462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is immediate imaging important in managing low back pain?
    Andersen JC
    J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures.
    Kwon J; Freijser L; Huynh E; Howell M; Chen G; Khan K; Daher S; Roberts N; Harrison C; Smith S; Devlin N; Howard K; Lancsar E; Bailey C; Craig J; Dalziel K; Hayes A; Mulhern B; Wong G; Ratcliffe J; Petrou S
    Pharmacoeconomics; 2022 Apr; 40(4):379-431. PubMed ID: 35072935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
    Yildirim H; Widdershoven CV; Aarts MJ; Bex A; Bloemendal HJ; Bochove-Overgaauw DM; Hamberg P; Herbschleb KH; van der Hulle T; Lagerveld BW; van Oijen MG; Oosting SF; van Thienen JV; van der Veldt AA; Westgeest HM; Zeijdner EE; Aben KK; van den Hurk C; Zondervan PJ; Bins AD
    BMC Cancer; 2023 Jul; 23(1):648. PubMed ID: 37434119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation approaches for enhancing interpretability of patient-reported outcomes (PROs) in meta-analysis: a protocol for a systematic survey of Cochrane reviews.
    Devji T; Johnston BC; Patrick DL; Bhandari M; Thabane L; Guyatt GH
    BMJ Open; 2017 Sep; 7(9):e017138. PubMed ID: 28963296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.
    Kyte D; Retzer A; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Turner G; Calvert M
    J Natl Cancer Inst; 2019 Nov; 111(11):1170-1178. PubMed ID: 30959516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid review of patient-reported outcomes investigated in the context of advanced renal cell cancer or advanced hepatocellular cancer.
    Diez de Los Rios de la Serna C; Kotronoulas G; Drury A; Oldenmenger W; Kelly D
    Eur J Oncol Nurs; 2023 Apr; 63():102241. PubMed ID: 36821884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported Outcome Measures in Metastatic Urinary Cancers.
    Bergerot CD; Bergerot PG; Philip EJ; Pal SK
    Eur Urol Focus; 2020 Jan; 6(1):26-30. PubMed ID: 30858072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.